<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02739789</url>
  </required_header>
  <id_info>
    <org_study_id>SBU Psychiatry Pilot</org_study_id>
    <nct_id>NCT02739789</nct_id>
  </id_info>
  <brief_title>Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study</brief_title>
  <official_title>Activating and Identifying Neural Responses to Social Rejection: a Combined Transcranial Direct Current Stimulation (tDCS) and Functional Magnetic Resonance Imaging (fMRI) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stony Brook University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study identifies neural pathways regulating negative moods during rejection by
      combining transcranial direct current stimulation (tDCS) and fMRI in a sample of healthy
      controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim 1: To test the behavioral effects of tDCS during social rejection. The first step will be
      to obtain behavioral effects of transcranial direct current stimulation (tDCS) during social
      rejection without functional magnetic resonance imaging (fMRI). Whereas previous studies used
      &quot;Cyberball&quot; (a computerized ball-tossing game that simulates social exclusion), we will use
      the Social Feedback Task. This task was created by Dr. Hsu to be more ethologically-relevant,
      has been shown to sustain negative moods during rejection and activates the right ventral
      lateral prefrontal cortex (rVLPFC) (preliminary fMRI data from 50 healthy controls in Dr.
      Hsu's previous study). Anodal tDCS will be applied over the right or left VLPFC to measure
      changes in mood during rejection and neutral conditions. Depending on results, alternate
      regions in separate subjects may also be stimulated: dorsolateral prefrontal cortex, insula,
      anterior cingulate cortex, pre-supplementary, and supplementary motor area [all regions may
      be right or left hemisphere]. All of these regions have been shown to be involved in emotion
      regulation. Questionnaires will be given before, during, and after the task to assess
      cognitive and emotional states.

      Aim 2: To identify neural pathways regulating negative moods during social rejection, using
      tDCS for activation and fMRI for assessment. Using a cross-over, sham-controlled design
      similar to previous tDCS+fMRI studies, we will measure the effects of anodal tDCS over the
      right or left VLPFC on neural activity and negative mood during rejection and neutral
      conditions. Alternate regions in separate subjects may also be stimulated including the
      dorsolateral prefrontal cortex, insula, anterior cingulate cortex, pre-supplementary, and
      supplementary motor area [all regions may be right or left hemisphere]. All of these regions
      have been shown to be involved in emotion regulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 14, 2018</start_date>
  <completion_date type="Actual">October 16, 2018</completion_date>
  <primary_completion_date type="Actual">October 16, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>within-subjects crossover design</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Oxygen Level Dependent (BOLD) Signal Changes (in Arbitrary Units)</measure>
    <time_frame>1-3 weeks</time_frame>
    <description>Images from fMRI scans for each participant are preprocessed (e.g., realigned, normalized, smoothed). Changes in BOLD signal are modeled for rejection and acceptance vs neutral blocks, and contrast images are created. These contrast images are used to compare tDCS vs sham for each subject in a within-subjects analysis. BOLD responses are reported as arbitrary units (i.e., change from sham stimulation). Regions of interest include left and right ventrolateral prefrontal cortex (VLPFC), left and right nucleus accumbens (NAcc), left and right amygdala (Amyg), left and right anterior insula (AI), left and right dorsal anterior cingulate cortex (dACC).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Positive and Negative Affect Scale (During fMRI)</measure>
    <time_frame>1-3 weeks</time_frame>
    <description>Change in emotion will be measured on the &quot;Positive and Negative Affect Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants rate how much they feel &quot;sad,&quot; &quot;rejected,&quot; &quot;happy,&quot; and &quot;accepted&quot; on a visual analog scale from &quot;not at all&quot; (minimum score of &quot;0&quot;) to &quot;extremely&quot; (maximum score of &quot;100&quot;).
Scores for &quot;sad&quot; were averaged with &quot;rejected,&quot; and scores for &quot;happy&quot; were averaged with &quot;accepted.&quot; The averaged scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant felt more of that particular emotion during a particular condition (minus neutral). Thus, a higher score for &quot;happy and accepted&quot; during the Acceptance-Neutral condition means a better outcome. Similarly, a lower score for &quot;happy and accepted' during Rejection-Neutral condition means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Single-item Self-Esteem Scale (During fMRI)</measure>
    <time_frame>1-3 weeks</time_frame>
    <description>Change in self-esteem will be measured on the &quot;Single-item Self-Esteem Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants respond to the item &quot;I have high self-esteem&quot; on a visual analog scale from &quot;not at all true of me&quot; (minimum score of &quot;0&quot;) to &quot;very true of me&quot; (maximum score of &quot;100&quot;).
Scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant had more self-esteem, and thus a better outcome, during a particular condition (minus neutral).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Desire for Social Interaction Scale (During fMRI)</measure>
    <time_frame>1-3 weeks</time_frame>
    <description>Change in Desire for Social Interaction will be measured on the &quot;Desire for Social Interaction Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants respond to four items measuring desire for social interaction (e.g., &quot;I would enjoy social interaction right now&quot;) on a visual analog scale from &quot;very slightly or not at all&quot; (minimum score of &quot;0&quot;) to &quot;extremely&quot; (maximum score of &quot;100&quot;).
Scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant had greater desire for social interaction, and thus a better outcome, during a particular condition (minus neutral).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tDCS stimulation will be administered over the brain area of interest</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>tDCS</description>
    <arm_group_label>Active tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tDCS</intervention_name>
    <description>Sham tDCS</description>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy males or females between 18 and 25 years old

          2. No diagnosis on Axis I by Structured Clinical Interview for Diagnostic and Statistical
             Manual of Mental Disorders IV. No current, or within the past 5 years.

          3. Not currently in a romantic relationship

          4. Ability to understand and follow instructions and oriented to name, time, and place.

          5. No additional neurologic or psychiatric disorders

          6. No current use of psychotropic drugs or during past 3 months (except marijuana and
             alcohol)

          7. No current use of marijuana or during past 3 weeks

          8. Not currently abusing alcohol

          9. No history of alcohol or drug dependence within past 5 years

         10. A negative urine pregnancy and toxicology screen. Verbal affirmation will be obtained
             (i.e., &quot;not pregnant&quot; and &quot;not currently using psychotropic drugs or during the past 3
             months&quot;) during the Screening Visit (Day 1). Urine screen will be obtained on Days 2
             and 3. If subject reports that there is a &quot;possibility that she is pregnant&quot; on Day 1
             (Screening Visit) a urine pregnancy screen will be performed on that day.

         11. (Women): If stopped or started oral contraceptives recently, at least 60 days on/off
             oral contraceptives.

        Exclusion Criteria:

          1. Left-handed or ambidextrous

          2. Metallic dental implants

          3. Metallic objects in the brain/skull

          4. Medical device implants

          5. Implanted electronic devices

          6. History of seizures

          7. History of strokes

          8. Unexplained loss of consciousness

          9. Frequent or severe headaches or neck pain

         10. Clinically significant, uncontrolled liver, kidney, cardiac, or pulmonary disease

         11. Terminal medical diagnosis consistent with survival &lt; 1 year

         12. Pregnancy; childbirth or miscarriage within 6 months, breastfeeding within 6 months of
             recruitment

         13. Serious mental impairment. Mini mental state exam of &lt; 23/30

         14. Chronic skin disease

         15. Previous experience with transcranial direct current stimulation (tDCS)

         16. Regular tobacco use or tobacco use within past month

         17. If using hormonal birth control, taking progestin-only pills (e.g., Cerazette,
             Ovrette), or Intrauterine devices (Mirena, Skyla), since progestin-only birth controls
             are more likely to cause mood swings.

        Addition Exclusion Criteria for participating in fMRI:

          1. Metal anywhere in the body

          2. Weight over 250 pounds, or girth size incompatible for scanner bore.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David T Hsu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stony Brook University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stony Brook University</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-8101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 1, 2016</study_first_submitted>
  <study_first_submitted_qc>April 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <results_first_submitted>May 11, 2020</results_first_submitted>
  <results_first_submitted_qc>June 20, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 8, 2020</results_first_posted>
  <last_update_submitted>June 20, 2020</last_update_submitted>
  <last_update_submitted_qc>June 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stony Brook University</investigator_affiliation>
    <investigator_full_name>David Hsu</investigator_full_name>
    <investigator_title>Assistant Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>tDCS rejection affect mood fMRI</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 21, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT02739789/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>This was a within-subjects design, thus every subject received both active and sham conditions</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sham tDCS First, Then Active tDCS</title>
          <description>Sham transcranial direct current stimulation (tDCS) on first scan day: tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment.
Active tDCS on second scan day: tDCS stimulation will be administered over the brain area of interest.</description>
        </group>
        <group group_id="P2">
          <title>Active tDCS First, Then Sham tDCS</title>
          <description>Active tDCS on first scan day: tDCS stimulation will be administered over the brain area of interest.
Sham tDCS on second scan day: tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First fMRI Scan</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>~1 Week Waiting Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second fMRI Scan</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham tDCS</title>
          <description>tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment
Sham tDCS: Sham tDCS</description>
        </group>
        <group group_id="B2">
          <title>Active tDCS</title>
          <description>tDCS stimulation will be administered over the brain area of interest
tDCS: tDCS</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.89" spread="2.37"/>
                    <measurement group_id="B2" value="21.71" spread="1.80"/>
                    <measurement group_id="B3" value="21.81" spread="2.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race/Ethnicity</title>
              <category_list>
                <category>
                  <title>White or Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>American Indian or Alaskan Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other or mixed</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Blood Oxygen Level Dependent (BOLD) Signal Changes (in Arbitrary Units)</title>
        <description>Images from fMRI scans for each participant are preprocessed (e.g., realigned, normalized, smoothed). Changes in BOLD signal are modeled for rejection and acceptance vs neutral blocks, and contrast images are created. These contrast images are used to compare tDCS vs sham for each subject in a within-subjects analysis. BOLD responses are reported as arbitrary units (i.e., change from sham stimulation). Regions of interest include left and right ventrolateral prefrontal cortex (VLPFC), left and right nucleus accumbens (NAcc), left and right amygdala (Amyg), left and right anterior insula (AI), left and right dorsal anterior cingulate cortex (dACC).</description>
        <time_frame>1-3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment
Sham tDCS: Sham tDCS</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest
tDCS: tDCS</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Oxygen Level Dependent (BOLD) Signal Changes (in Arbitrary Units)</title>
          <description>Images from fMRI scans for each participant are preprocessed (e.g., realigned, normalized, smoothed). Changes in BOLD signal are modeled for rejection and acceptance vs neutral blocks, and contrast images are created. These contrast images are used to compare tDCS vs sham for each subject in a within-subjects analysis. BOLD responses are reported as arbitrary units (i.e., change from sham stimulation). Regions of interest include left and right ventrolateral prefrontal cortex (VLPFC), left and right nucleus accumbens (NAcc), left and right amygdala (Amyg), left and right anterior insula (AI), left and right dorsal anterior cingulate cortex (dACC).</description>
          <units>Arbitrary units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>left VLPFC (Rejection-Neutral)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".57" spread=".77"/>
                    <measurement group_id="O2" value=".66" spread=".80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right VLPFC (Rejection-Neutral)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".25" spread=".49"/>
                    <measurement group_id="O2" value=".29" spread=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left VLPFC (Acceptance-Neutral)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".67" spread=".84"/>
                    <measurement group_id="O2" value=".33" spread=".77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right VLPFC (Acceptance-Neutral)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".40" spread="1.14"/>
                    <measurement group_id="O2" value=".31" spread=".72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left NAcc (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".01" spread=".25"/>
                    <measurement group_id="O2" value=".18" spread=".42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right NAcc (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".05" spread=".30"/>
                    <measurement group_id="O2" value=".24" spread=".53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left NAcc (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".09" spread=".38"/>
                    <measurement group_id="O2" value=".27" spread=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right NAcc (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".17" spread=".38"/>
                    <measurement group_id="O2" value=".34" spread=".58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left Amyg (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".2" spread=".36"/>
                    <measurement group_id="O2" value=".39" spread=".45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right Amyg (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".19" spread=".41"/>
                    <measurement group_id="O2" value=".35" spread=".52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left Amyg (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".12" spread=".43"/>
                    <measurement group_id="O2" value=".11" spread=".23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right Amyg (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".07" spread=".43"/>
                    <measurement group_id="O2" value=".19" spread=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left AI (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".32" spread=".49"/>
                    <measurement group_id="O2" value=".38" spread=".53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right AI (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".28" spread=".49"/>
                    <measurement group_id="O2" value=".23" spread=".61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left AI (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".36" spread=".60"/>
                    <measurement group_id="O2" value=".32" spread=".44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right AI (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".21" spread=".86"/>
                    <measurement group_id="O2" value=".17" spread=".41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left dACC (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".04" spread=".60"/>
                    <measurement group_id="O2" value=".25" spread=".67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right dACC (R-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".13" spread=".45"/>
                    <measurement group_id="O2" value=".21" spread=".72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left dACC (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".09" spread=".6"/>
                    <measurement group_id="O2" value=".42" spread=".62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>right dACC (A-N)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".06" spread=".59"/>
                    <measurement group_id="O2" value=".32" spread=".67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Positive and Negative Affect Scale (During fMRI)</title>
        <description>Change in emotion will be measured on the &quot;Positive and Negative Affect Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants rate how much they feel &quot;sad,&quot; &quot;rejected,&quot; &quot;happy,&quot; and &quot;accepted&quot; on a visual analog scale from &quot;not at all&quot; (minimum score of &quot;0&quot;) to &quot;extremely&quot; (maximum score of &quot;100&quot;).
Scores for &quot;sad&quot; were averaged with &quot;rejected,&quot; and scores for &quot;happy&quot; were averaged with &quot;accepted.&quot; The averaged scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant felt more of that particular emotion during a particular condition (minus neutral). Thus, a higher score for &quot;happy and accepted&quot; during the Acceptance-Neutral condition means a better outcome. Similarly, a lower score for &quot;happy and accepted' during Rejection-Neutral condition means a worse outcome.</description>
        <time_frame>1-3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment
Sham tDCS: Sham tDCS</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest
tDCS: tDCS</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Positive and Negative Affect Scale (During fMRI)</title>
          <description>Change in emotion will be measured on the &quot;Positive and Negative Affect Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants rate how much they feel &quot;sad,&quot; &quot;rejected,&quot; &quot;happy,&quot; and &quot;accepted&quot; on a visual analog scale from &quot;not at all&quot; (minimum score of &quot;0&quot;) to &quot;extremely&quot; (maximum score of &quot;100&quot;).
Scores for &quot;sad&quot; were averaged with &quot;rejected,&quot; and scores for &quot;happy&quot; were averaged with &quot;accepted.&quot; The averaged scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant felt more of that particular emotion during a particular condition (minus neutral). Thus, a higher score for &quot;happy and accepted&quot; during the Acceptance-Neutral condition means a better outcome. Similarly, a lower score for &quot;happy and accepted' during Rejection-Neutral condition means a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rejection-Neutral conditions (sad and rejected)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.06" spread="18.82"/>
                    <measurement group_id="O2" value="12.81" spread="14.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptance-Neutral conditions (sad and rejected)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.00" spread="20.63"/>
                    <measurement group_id="O2" value="-3.33" spread="13.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rejection-Neutral conditions (happy and accepted)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.94" spread="22.89"/>
                    <measurement group_id="O2" value="-5.31" spread="20.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptance-Neutral conditions (happy and accepted)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="22.20"/>
                    <measurement group_id="O2" value="12.00" spread="25.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in the Single-item Self-Esteem Scale (During fMRI)</title>
        <description>Change in self-esteem will be measured on the &quot;Single-item Self-Esteem Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants respond to the item &quot;I have high self-esteem&quot; on a visual analog scale from &quot;not at all true of me&quot; (minimum score of &quot;0&quot;) to &quot;very true of me&quot; (maximum score of &quot;100&quot;).
Scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant had more self-esteem, and thus a better outcome, during a particular condition (minus neutral).</description>
        <time_frame>1-3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment
Sham tDCS: Sham tDCS</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest
tDCS: tDCS</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Single-item Self-Esteem Scale (During fMRI)</title>
          <description>Change in self-esteem will be measured on the &quot;Single-item Self-Esteem Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants respond to the item &quot;I have high self-esteem&quot; on a visual analog scale from &quot;not at all true of me&quot; (minimum score of &quot;0&quot;) to &quot;very true of me&quot; (maximum score of &quot;100&quot;).
Scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant had more self-esteem, and thus a better outcome, during a particular condition (minus neutral).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rejection-Neutral conditions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.33" spread="18.46"/>
                    <measurement group_id="O2" value="-2.67" spread="21.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptance-Neutral conditions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="12.69"/>
                    <measurement group_id="O2" value="8.57" spread="28.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Desire for Social Interaction Scale (During fMRI)</title>
        <description>Change in Desire for Social Interaction will be measured on the &quot;Desire for Social Interaction Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants respond to four items measuring desire for social interaction (e.g., &quot;I would enjoy social interaction right now&quot;) on a visual analog scale from &quot;very slightly or not at all&quot; (minimum score of &quot;0&quot;) to &quot;extremely&quot; (maximum score of &quot;100&quot;).
Scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant had greater desire for social interaction, and thus a better outcome, during a particular condition (minus neutral).</description>
        <time_frame>1-3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment
Sham tDCS: Sham tDCS</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>tDCS stimulation will be administered over the brain area of interest
tDCS: tDCS</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Desire for Social Interaction Scale (During fMRI)</title>
          <description>Change in Desire for Social Interaction will be measured on the &quot;Desire for Social Interaction Scale.&quot; During Rejection, Acceptance, and Neutral conditions, participants respond to four items measuring desire for social interaction (e.g., &quot;I would enjoy social interaction right now&quot;) on a visual analog scale from &quot;very slightly or not at all&quot; (minimum score of &quot;0&quot;) to &quot;extremely&quot; (maximum score of &quot;100&quot;).
Scores during Neutral were subtracted from Rejection and Acceptance to derive the outcome measures.
Higher outcome measure score means that the participant had greater desire for social interaction, and thus a better outcome, during a particular condition (minus neutral).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rejection-Neutral conditions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-16.88" spread="35.72"/>
                    <measurement group_id="O2" value="-13.75" spread="30.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptance-Neutral conditions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.00" spread="14.24"/>
                    <measurement group_id="O2" value="1.33" spread="19.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected over the duration of time over which each participant was assessed. This was an average of 30 days (standard deviation = 16 days, range = 14 - 74 days).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sham tDCS</title>
          <description>Sham tDCS: tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the &quot;active&quot; treatment.
All participants received sham tDCS, either on the first or second scan day.</description>
        </group>
        <group group_id="E2">
          <title>Active tDCS</title>
          <description>Active tDCS: tDCS stimulation will be administered over the brain area of interest.
All participants received active tDCS, either on the first or second scan day.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David Hsu, Assistant Professor of Psychiatry</name_or_title>
      <organization>Stony Brook University</organization>
      <phone>(631) 638-1522</phone>
      <email>david.hsu@stonybrookmedicine.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

